Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Vivimed Labs Ltd

NSE: VIVIMEDLAB · BSE: 532660 · Pharmaceuticals & Biotechnology · 4 announcements

Share price
₹5.55
Market cap
₹46.02 Cr
Revenue (annual)
₹69.99 Cr
Net profit (annual)
₹-176.5 Cr
P/E (TTM)
-0.3×Sector 50.4×
Promoter holding
7.57%-0.20% QoQ
FII holding
1.64%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

20:38 IST BSE
Insolvency Petition

Vivimed Labs Insolvency Petition

Vivimed Labs Limited, currently under CIRP, has scheduled the 8th meeting of the Committee of Creditors for September 29, 2026, via audio-visual means.

14:41 IST BSE
Other Announcement

Vivimed Labs Other Announcement

Vivimed Labs is seeking a three-month extension from the Registrar of Companies to convene its Annual General Meeting for the financial year 2025-26.